Plasma phospholipid transfer activity is essential for increased atherogenesis in PLTP transgenic mice: A mutation-inactivation study

Journal of Lipid Research

Volumn 49, Issue 12, 2008, Pages 2504-2512

  Samyn, Hannelore ^a   Moerland, Matthijs ^a   van Gent, Teus ^a   van Haperen, Rien ^a   Metso, Jari ^b   Grosveld, Frank ^a   Jauhiainen, Matti ^b   van Tol, Arie ^a   de Crom, Rini ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Atherosclerosis; Lipoproteins; Phospholipid transfer protein

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MUTANT PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PHOSPHOLIPID TRANSFER PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DISEASE MODEL; GENE ACTIVITY; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HETEROZYGOSITY; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIPOPROTEIN SECRETION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; GENETICS; METABOLISM; MUTATION;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; LIPOPROTEINS, VLDL; MICE; MICE, TRANSGENIC; MUTATION; PHOSPHOLIPID TRANSFER PROTEINS; RNA, MESSENGER;

EID: 59649115768     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800080-JLR200     Document Type: Article

References (40)

1. Tall, A. R., and P. H. Green. 1981. Incorporation of phosphatidylcholine into spherical and discoidal lipoproteins during incubation of egg phosphatidylcholine vesicles with isolated high density lipoproteins or with plasma. J. Biol. Chem. 256: 2035-2044.
2. Tall, A. R., S. Krumholz, T. Olivecrona, and R. J. Deckelbaum. 1985. Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J. Lipid Res. 26: 842-851.
3. Rao, R., J. J. Albers, G. Wolfbauer, and H. J. Pownall. 1997. Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Biochemistry. 36: 3645-3653.
4. Nishida, H. I., and T. Nishida. 1997. Phospholipid transfer protein mediates transfer of not only phosphatidylcholine but also cholesterol from phosphatidylcholine-cholesterol vesicles to high density lipoproteins. J. Biol. Chem. 272: 6959-6964.
5. Hailman, E., J. J. Albers, G. Wolfbauer, A. Y. Tu, and S. D. Wright. 1996. Neutralization and transfer of lipopolysaccharide by phospholipid transfer protein. J. Biol. Chem. 271: 12172-12178.
6. Levels, J. H., J. A. Marquart, P. R. Abraham, A. E. van den Ende, H. O. Molhuizen, S. J. van Deventer, and J. C. Meijers. 2005. Lipo-polysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infect. Immun. 73: 2321-2326.
7. Kostner, G. M., K. Oettl, M. Jauhiainen, C. Ehnholm, H. Esterbauer, and H. Dieplinger. 1995. Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells. Biochem. J. 305: 659-667.
8. Jauhiainen, M., J. Metso, R. Pahlman, S. Blomqvist, A. van Tol, and C. Ehnholm. 1993. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J. Biol. Chem. 268: 4032-4036.
9. Tu, A. Y., H. I. Nishida, and T. Nishida. 1993. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J. Biol. Chem. 268: 23098-23105.
10. Moerland, M., H. Samyn, T. van Gent, M. Jauhiainen, J. Metso, R. van Haperen, F. Grosveld, A. van Tol, and R. de Crom. 2007. Atherogenic, enlarged, and dysfunctional HDL in human PLTP/apoA-I double transgenic mice. J. Lipid Res. 48: 2622-2631.
11. Huuskonen, J., V. M. Olkkonen, C. Ehnholm, J. Metso, I. Julkunen, and M. Jauhiainen. 2000. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Biochemistry. 39: 16092-16098.
12. Jiang, X. C., C. Bruce, J. Mar, M. Lin, Y. Ji, O. L. Francone, and A. R. Tall. 1999. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 103: 907-914.
13. Jiang, X. C., S. Qin, C. Qiao, K. Kawano, M. Lin, A. Skold, X. Xiao, and A. R. Tall. 2001. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat. Med. 7: 847-852.
14. Jiang, X. C., A. R. Tall, S. Qin, M. Lin, M. Schneider, F. Lalanne, V. Deckert, C. Desrumaux, A. Athias, J. L. Witztum, et al. 2002. Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E. J. Biol. Chem. 277: 31850-31856.
15. van Haperen, R., A. van Tol, P. Vermeulen, M. Jauhiainen, T. van Gent, P. van den Berg, S. Ehnholm, F. Grosveld, A. van der Kamp, and R. de Crom. 2000. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 20: 1082-1088.
16. van Haperen, R., A. van Tol, T. van Gent, L. Scheek, P. Visser, A. van der Kamp, F. Grosveld, and R. de Crom. 2002. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 277: 48938-48943.
17. Jaari, S., K. W. van Dijk, V. M. Olkkonen, A. van der Zee, J. Metso, L. Havekes, M. Jauhiainen, and C. Ehnholm. 2001. Dynamic changes in mouse lipo roteins induced by transiently expressed human phospbolipid t ansfer protein (PLTP): importance of PLTP in prebeta-HDL generation. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 128: 781-792.
18. Oka, T., T. Kujiraoka, M. Ito, T. Egashira, S. Takahashi, M. N. Nanjee, N. E. Miller, J. Metso, V. M. Olkkonen, C. Ehnholm, et al. 2000. Distribution of phospholipid transfer protein in human plasma: presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive. J. Lipid Res. 41: 1651-1657.
19. Jonkers, I. J., A. H. Smelt, H. Hattori, L. M. Scheek, T. van Gent, F. H. de Man, A. van der Laarse, and A. van Tol. 2003. Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy. J. Lipid Res. 44: 1462-1469.
20. Huuskonen, J., G. Wohlfahrt, M. Jauhiainen, C. Ehnholm, O. Teleman, and V. M. Olkkonen. 1999. Structure and phospholipid transfer activity of human PLTP: analysis by molecular modeling and site-directed mutagenesis. J. Lipid Res. 40: 1123-1130.
21. Anttolainen, M., L. M. Valsta, G. Alfthan, P. Kleemola, I. Salminen, and M. Tamminen. 1996. Effect of extreme fish consumption on dietary and plasma antioxidant levels and fatty acid composition. Eur. J. Clin. Nutr. 50: 741-746.
22. Oka, T., T. Kujiraoka, M. Ito, M. Nagano, M. Ishihara, T. Iwasaki, T. Egashira, N. E. Miller, and H. Hattori. 2000. Measurement of human plasma phospholipid transfer protein by sandwich ELISA. Clin. Chem. 46: 1357-1364.
23. Clark, R. W., J. B. Moberly, and M. J. Bamberger. 1995. Low level quantification of cholesteryl ester transfer protein in plasma subfractions and cell culture media by monoclonal antibody-based immunoassay. J. Lipid Res. 36: 876-889.
24. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
25. Yatsuya, H., K. Tamakoshi, H. Hattori, R. Otsuka, K. Wada, H. Zhang, T. Mabuchi, M. Ishikawa, C. Murata, T. Yoshida, et al. 2004. Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases. Circ. J. 68: 11-16.
26. Schgoer, W., T. Mueller, M. Jauhiainen, A. Wehinger, R. Gander, I. Tancevski, K. Salzmann, P. Eller, A. Ritsch, M. Haltmayer, et al. 2008. Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis. Atherosclerosis. 196: 219-226.
27. Schlitt, A., C. Bickel, P. Thumma, S. Blankenberg, H. J. Rupprecht, J. Meyer, and X. C. Jiang. 2003. High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23: 1857-1862.
28. Ruhling, K., A. Lang, F. Richard, A. van Tol, B. Eisele, V. Herzberg, and U. Till. 1999. Net mass transfer of plasma cholesteryl esters and lipid transfer proteins in normolipidemic patients with peripheral vascular disease. Metabolism. 48: 1361-1366.
29. Tall, A. R. 1986. Plasma lipid transfer proteins. J. Lipid Res. 27: 361-367.
30. Speijer, H., J. E. Groener, E. van Ramshorst, and A. van Tol. 1991. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis. 90: 159-168.
31. Lusa, S., M. Jauhiainen, J. Metso, P. Somerharju, and C. Ehnholm. 1996. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem. J. 313: 275-282.
32. Foger, B., S. Santamarina-Fojo, R. D. Shamburek, C. L. Parrot, G. D. Talley, and H. B. Brewer, Jr. 1997. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J. Biol. Chem. 272: 27393-27400.
33. Fielding, C. J., and P. E. Fielding. 2001. Cellular cholesterol efflux. Biochim. Biophys. Acta. 1533: 175-189.
34. Wirtz, K. W. 2006. Phospholipid transfer proteins in perspective. FEBS Lett. 580: 5436-5441.
35. Urizar, N. L., D. H. Dowhan, and D. D. Moore. 2000. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J. Biol. Chem. 275: 39313-39317.
36. O'Brien, K. D., S. Vuletic, T. O. McDonald, G. Wolfbauer, K. Lewis, A. Y. Tu, S. Marcovina, T. N. Wight, A. Chait, and J. J. Albers. 2003. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation. 108: 270-274.
37. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
38. Liu, R., M. R. Hojjati, C. M. Devlin, I. H. Hansen, and X. C. Jiang. 2007. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27: 190-196.
39. Valenta, D. T., N. Ogier, G. Bradshaw, A. S. Black, D. J. Bonnet, L. Lagrost, L. K. Curtiss, and C. M. Desrumaux. 2006. Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression. Arterioscler. Thromb. Vasc. Biol. 26: 1572-1578.
40. Vikstedt, R., D. Ye, J. Metso, R. B. Hildebrand, T. J. Van Berkel, C. Ehnholm, M. Jauhiainen, and M. Van Eck. 2007. Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development. Arterioscler. Thromb. Vasc. Biol. 27: 578-586.